Study to Evaluate Injection Pain and Local Tolerability Following Administration of TV-46046

- Contraception
- Completed

Study Title: A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous Administration of TV-46046

Teva Identifier: TV46046-WH-10147

ClinicalTrials.gov Identifier: NCT03700658

Study Status: Completed

Trial Condition(s): Contraception

Interventions: Drug: TV-46046 - 1 | Drug: TV-46046 - 2 | Drug: medroxyprogesterone acetate injectable suspension | Drug: TV-46046 Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female

Age group: Adult

Age Range: 18 Years to 50 Years

Trial Duration: December 14, 2018 - October 2, 2020

Phase: Phase 1

Study Type

Interventional